The choice of a tocolytic for the treatment of preterm labor: a critical evaluation of nifedipine versus atosiban

Bibliography

• SPELLACY WN, CRUZ AC, BIRK SA et al.: Treatment of premature labor with ritodrine: a randomized controlled study. Obstet. Gynecol. (1979) 54:220-223.
   PubMed Web of Science ®Google Scholar
• BESINGER R, IANNUCCI TA: Tocolytic therapy. In: Preterm Labor. Elder MG, Lamont RF, Romero R (Eds), Churchill Livingston, New York, USA (1997):243-297.
   Google Scholar
• THE CANADIAN PRETERMLABOUR INVESTIGATOR GROUP: Treatment of preterm labor with the β-adrenergic agonist ritodrine. N. Engl. J. Med. (1992) 327:308-312.
   PubMed Web of Science ®Google Scholar
• LEVENO KJ, CUNNINGHAM FG: β-Adrenergic agonists for preterm labor. N. Engl. J. Med. (1992) 327:349-351.
   PubMed Web of Science ®Google Scholar
• FILICORI M, COGNIGNI GE, GAMBERINI E, TROILO E, PERMEGIANI L, BERNARDI S: Impact of medically assisted fertility on preterm birth. BJOG (2005) 112(Suppl. 1):113-117.
   PubMed Web of Science ®Google Scholar
• FINNSTROM O, OLAUSSON PO, SEDIN G et al.: The Swedish national prospective study on extremely low birthweight (ELBW) infants. Incidence, mortality, morbidity and survival in relation to level of care. Acta Paediatr. (1997) 86:503-511.
   PubMed Web of Science ®Google Scholar
• DI RENZO GC, AL-SALEH E, MATTEI A, KOUTRAS I, CLERICI G. Use of tocolytics: what is the benefit of gaining 48 hours for the fetus? BJOG (2006) 113(Suppl. 3):72-77.
   PubMed Web of Science ®Google Scholar
• MAGOWAN BA, BAIN M, JUSZCZAK E et al.: Neonatal mortality amongst Scottish preterm singleton births (1985-1994). BJOG (1998) 105:1005-1010.
   Web of Science ®Google Scholar
• National Institutes of Health Consensus Development Conference Statement: effect of corticosteroids for fetal maturation on perinatal outcomes. Am. J. Obstet. Gynecol. (1995) 173:246-252.
   Web of Science ®Google Scholar
• KEIRSE MJ: The history of tocolytics. BJOG (2003) 110(S20):94-97.
   PubMed Web of Science ®Google Scholar
• VALENZUELA GJ, SANCHEZ-RAMOS L, ROMERO R et al.: Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. Am. J. Obstet. Gynecol. (2000) 182:1184-1190.
   PubMed Web of Science ®Google Scholar
• HOLLEBOOM CA, MERKUS JM, VAN EFFEREN LM, KEIRSE MJ: Double blind evaluation of ritodrine sustained release for oral maintenance of tocolysis after active preterm labour. BJOG (1996) 103:702-705.
   Web of Science ®Google Scholar
• MATIJEVIC R, GRGIC O, VASILJ O: Ritodrine in oral maintenance of tocolysis after active preterm labor: randomised controlled trial. Croat. Med. J. (2006) 47:25-31.
   PubMed Web of Science ®Google Scholar
• THORNTON JG: Maintenance tocolysis. BJOG (2005) 112(Suppl. 1):118-121.
   PubMed Web of Science ®Google Scholar
• MOUTQUIN JM, CABROL D, FISK NM et al.: Effectiveness and safety of the oxytocin antagonist atosiban versus β-adrenergic agonists in the treatment of preterm labour. Worldwide comparative study atosiban v β-agonists. BJOG (2001) 108:133-142.
   PubMed Web of Science ®Google Scholar
• LAMONT RF, DUNLOP PD, CROWLEY P et al.: Comparative mortality and morbidity of infants transferred in utero or postnatally. J. Perinat. Med. (1983) 11:200-203.
   PubMed Web of Science ®Google Scholar
• DOWNEY LJ, MARTIN AJ: Ritodrine in the treatment of preterm labour: a study of 213 patients. BJOG (1983) 90:1046-1053.
   Web of Science ®Google Scholar
• LAMONT RF: The pathophysiology of pulmonary oedema with use of β-agonists. BJOG (2000) 107:439-444.
   PubMed Web of Science ®Google Scholar
• ROYAL COLLEGE OF OBSTETRICIANSAND GYNAECOLOGISTS: β-Agonists for the Care of Women in Labour. Guideline no. 1. RCOG Press, London, UK (1997).
   Google Scholar
• ROYAL COLLEGE OF OBSTETRICIANSAND GYNAECOLOGISTS: Tocolytic Drugs for Women in Preterm Labour. Clinical guideline no. 1[B]. RCOG Press, London, UK (2002).
   Google Scholar
• LAMONT RF: The development and introduction of anti-oxytocic tocolytics. BJOG (2003) 110(Suppl. 20):108-112.
   PubMed Web of Science ®Google Scholar
• AKERLUND M, STRÖMBERG P, HAUKSSON A et al.: Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot study. BJOG (1987) 94:1040-1044.
   Web of Science ®Google Scholar
• ANDERSON L-F, LYNDRUP J, AKERLUND M, MERLIN P: Oxytocin receptor blockade: a new principle in the treatment of preterm labour. Am. J. Perinatol. (1989) 6:196-199.
   PubMed Web of Science ®Google Scholar
• GOODWIN TM, PAUL RP, SILVER H et al.: The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human. Am. J. Obstet. Gynecol. (1994) 170:474-478.
   PubMed Web of Science ®Google Scholar
• GOODWIN TM, VALENZUELA GJ, SILVER H AND THE ATOSIBAN STUDY GROUP: Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Obstet. Gynecol. (1996) 88:331-336.
   PubMed Web of Science ®Google Scholar
• GOODWIN TM, VALENZUELA GJ, SILVER H et al.: Treatment of preterm labor with the oxytocin antagonist atosiban. Am. J. Perinat. (1996) 13:143-146.
   PubMed Web of Science ®Google Scholar
• ROMERO R, SIBAL BM, SANCHEZ-RAMOS L et al.: An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am. J. Obstet. Gynecol. (2000) 182:1173-1183.
   PubMed Web of Science ®Google Scholar
• LAMONT RF, JAGGAT A: Emerging drug therapies for prevention of spontaneous preterm labour and preterm birth. Expert Opin. Invest. Drugs (2007) 16(3):337-345.
   PubMed Web of Science ®Google Scholar
• MARŠÁL K, FISK NM, CALDER AA et al.: The oxytocin antagonist atosiban versus the β-agonist terbutaline in the treatment of preterm labor. Acta Obstet. Gynecol. Scand. (2001) 80:413-422.
   PubMed Web of Science ®Google Scholar
• CABROL D, GILLET JY, MADELENAT P et al.: Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. Eur. J. Obstet. Gynecol. (2001) 98:77-85.
   Web of Science ®Google Scholar
• MOUTQUIN J-M, SHERMAN D, COHEN H et al.: Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicentre effectiveness and safety study. Am. J. Obstet. Gynecol. (2000) 182:1191-1199.
   PubMed Web of Science ®Google Scholar
• HUSSLEIN P, QUARTAROLO J-P: Review of clinical experience with atosiban and the Tractocile Efficacy Assessment Survey in Europe (TREASURE) study protocol. Int. J. Clin. Pract. (2003) 57:121-127.
   PubMed Web of Science ®Google Scholar
• LOCCI M, NAZZANO G, MERENDA A et al.: Atosiban versus ritodrine used prophylactically with cerclage in ICSI pregnancies to prevent preterm birth in women identified as being at high risk on the basis of transvaginal ultrasound scan. J. Obstet. Gynaecol. (2006) 26:396-401.
   PubMedGoogle Scholar
• OEI SG, MOL BW, DE KLEINE MJ, BROLMANN HA: Nifedipine versus ritodrine for suppression of preterm labor; a meta-analysis. Acta Obstet. Gynecol. Scand. (1999) 78:783-788.
   PubMed Web of Science ®Google Scholar
• TSATSIRIS V, PAPATSONIS D, GOFFINET F, DECKER G, CARBONNE B: Tocolysis with nifedipine or β-adrenergic agonists: a meta-analysis. Obstet. Gynecol. (2001) 97(2):840-847.
   PubMed Web of Science ®Google Scholar
• KING JF, FLENADY VJ, PAPATSONIS DN et al.: Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst. Rev. (2003) 1:1-50 (CD002255).
   Google Scholar
• KING JF, FLENADY VJ, PAPATSONIS DN et al.: Calcium channel blockers for inhibiting preterm labour; a systematic review of the evidence and a protocol for administration of nifedipine. Aust. N. Z. J. Obstet. Gynaecol. (2003) 43:192-198.
   PubMed Web of Science ®Google Scholar
• KOKS AM, BRÖLMANN HAM, DE KLEINE M, MANGER PA: A randomized comparison of nifedipine and ritodrine for suppression of preterm labor. Eur. J. Obstet. Gynecol. Reprod. Biol. (1998) 77:171-176.
   PubMed Web of Science ®Google Scholar
• LARMON JE, ROSS BS, MAY WL: Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor. Am. J. Obstet. Gynecol. (1999) 181:1432-1437.
   PubMed Web of Science ®Google Scholar
• WEERAKUL W, CHITTACHAROEN A, SUTHUTVORAVUT S: Nifedipine versus terbutaline in the management of preterm labor. Int. J. Gynaecol. Obstet. (2002) 76:311-313.
   PubMed Web of Science ®Google Scholar
• PAPATSONIS DNM, VAN GEIJN HP, ADÈR HJ, LANGE FM, BLEKERE OP, DEKKER GA: Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet. Gynecol. (1997) 90:23-34.
   Google Scholar
• TSATSIRIS V, CARBONNE B, PAPATSONIS D, GOFFINET F: Comment on: nifedipine versus ritodrine for suppression of preterm labor; a meta-analysis. Acta Obstet. Gynecol. Scand. (2000) 79:618-619.
   PubMedGoogle Scholar
• LAMONT RF, KHAN KS, BEATTIE B et al.: The quality of nifedipine studies used to assess tocolytic efficacy: a systematic review. J. Perinat. Med. (2005) 33:287-295.
   PubMed Web of Science ®Google Scholar
• BAL L, THIERRY S, BROCAS E et al.: Pulmonary edema induced by calcium channel blockade for tocolysis. Anesth. Analg. (2004) 99:910-911.
   PubMed Web of Science ®Google Scholar
• VAAST P, DUBREUCQ-FOSSAERT S, HOUFFLIN-DEBARGE V et al.: Acute pulmonary oedema during nicardipine therapy for premature labour: report of five cases. Eur. J. Obstet. Gynecol. Reprod. Biol. (2004) 113:98-99.
   PubMed Web of Science ®Google Scholar
• OEI SG, OEI SK, BRÖLMANN HAM: Myocardial infarction during nifedipine therapy for preterm labor. N. Engl. J. Med. (1999) 340:154-155.
   PubMed Web of Science ®Google Scholar
• VERHAERT D, VAN ACKER R: Acute myocardial infarction during pregnancy. Acta Cardiol. (2004) 59:331-339.
   PubMed Web of Science ®Google Scholar
• VAN VEEN AJ, PELINCK MJ, VAN PAMPUS MG, ERWICH JJ: Severe hypotension and fetal death due to tocolysis with nifedipine. BJOG (2005) 112:509-510.
   PubMed Web of Science ®Google Scholar
• HODGES R, BARKEHALL-THOMAS A, TIPPETT C: Maternal hypoxia associated with nifedipine for threatened preterm labour. BJOG (2004) 111:380-381.
   PubMed Web of Science ®Google Scholar
• PARASURAMAN R, GANDHI MM, LIVERSEDGE NH: Nifedipine tocolysis associated atrial fibrillation responds to DC carioversion. BJOG (2006) 113:844-845.
   PubMed Web of Science ®Google Scholar
• SCHOLTZ H: Pharmacological aspects of calcium channel blockers. Cardiovasc. Drugs Ther. (1997) 10(3):869-872.
   PubMed Web of Science ®Google Scholar
• PAPATSONIS D, FLENADY V, COLE S, LILEY H: Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst. Rev. (2005) 3:CD004452.
   PubMedGoogle Scholar
• AKERLUND M: Targeting the oxytocin receptor to relax the myometrium. Expert Opin. Ther. Targets (2006) 10(3):423-427.
   PubMed Web of Science ®Google Scholar
• HEINONEN S: Critical evaluation of evidence: a lesson to learn from a recent meta-analysis. Acta Obstet. Gynecol. Scand. (2006) 85:260-262.
   PubMed Web of Science ®Google Scholar
• RICHTER ON, DORN C, VAN DE VONDEL P, ULRICH U, SCHMOLLING J: Tocolysis with atosiban: experience in the management of premature labor before 24 weeks of pregnancy. Arch. Gynecol. Obstet. (2005) 272:26-30.
   PubMedGoogle Scholar
• GREIG PC, MASSMAN GA, DEMAREST KT, WEGLEIN RC, HOLLAND ML, FIGUEROA JP: Maternal and fetal cardiovascular effects and placental transfer of the oxytocin antagonist atosiban in late gestation pregnant sheep. Am. J. Obstet. Gynecol. (1993) 169:897-902.
   PubMed Web of Science ®Google Scholar
• COOMARASAMY A, KNOX EM, GEE H et al.: Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: a meta-analysis with an indirect comparison of randomized trials. BJOG (2003) 110:1045-1049.
   PubMed Web of Science ®Google Scholar
• KASHANIAN M, AKBARIAN AR, SOLTANZADEH M: Atosiban and nifedipine for the treatment of preterm labor. Int. J. Gynaecol. Obstet. (2005) 91:10-14.
   PubMed Web of Science ®Google Scholar
• AL-OMARI WR, AL-SHAMMAA, AL-TIKRITI EM, AHMED KW: Atosiban and nifedipine in acute tocolysis: a comparative study. Eur. J. Obstet. Gynecol. Reprod. Biol. (2006) 128:129-134.
   PubMed Web of Science ®Google Scholar
• PAPATSONIS DN, VAN GEIJN HP, DEKKER GA: Management of preterm labour. Nifedipine in management of preterm labour is safe. Br. Med. J. (1999) 319:257.
   PubMedGoogle Scholar
• PAPATSONIS DN, KOK JH, VAN GEIJN HP, BLEKER OP, ADER HJ, DEKKER GA: Neonatal effects of nifedipine and ritodrine for preterm labor. Obstet. Gynecol. (2000) 95:477-481.
   PubMed Web of Science ®Google Scholar
• PAPATSONIS DN, VAN GEIJN HP, DEKKER GA: Nifedipine as a safe and effective tocolytic agent in the treatment of preterm labour. Am. J. Obstet. Gynecol. (2000) 183:513-514.
   PubMed Web of Science ®Google Scholar
• PAPATSONIS DN, LOK CA, BOS JM, VAN GEIJN HP, DEKKER GA: Calcium channel blockers in the management of preterm labor and hypertension in pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. (2001) 97:122-140.
   PubMed Web of Science ®Google Scholar
• PAPATSONIS DN, TIMMERMAN CC, OEI SG, VAN GEIJN HP: Nifedipine first choice in management of threatening preterm labor. Ned. Tijdschr. Geneeskd (2002) 146:1980-1983.
   PubMedGoogle Scholar
• PAPATSONIS DN, VAN GEIJN HP, BLEKER OP, ADER HJ, DEKKER GA: Hemodynamic and metabolic effects after nifedipine and ritodrine tocolysis. Int. J. Gynaecol. Obstet. (2003) 82:5-10.
   PubMed Web of Science ®Google Scholar
• MITTENDORF R, PRYDE PG: A review of the role for magnesium sulphate in preterm labour. BJOG (2005) 112(I):84-88.
   PubMedGoogle Scholar
• GRIMES DA, NANDA K: Magnesium sulfate tocolysis: time to quit. Obstet. Gynecol. (2006) 108:986-989.
   PubMed Web of Science ®Google Scholar
• KEIRSE MJ: New perspectives for the effective treatment of preterm labor. Am. J. Obstet. Gynecol. (1995) 173:618-628.
   PubMed Web of Science ®Google Scholar
• PETROU S: Economic consequences of preterm birth and low birthweight. BJOG (2003) 110(Suppl. 20):17-23.
   PubMed Web of Science ®Google Scholar
• GILBERT WM, NESBITT TS, DANIELSEN B: The cost of prematurity: quantification by gestational age and birth weight. Obstet. Gynecol. (2003) 102:488-493.
   PubMed Web of Science ®Google Scholar
• KOS M, WERTHEIMER AI, MRHAR A: Satisfaction with pharmacotherapy for approved and off-label indications – a Delphi study. Ann. Pharmacother. (2005) 39:649-654.
   PubMed Web of Science ®Google Scholar
• THORNTON J: The drugs we deserve. BJOG (2003) 110:969-970.
   PubMed Web of Science ®Google Scholar